Use Case · Personalization & Orchestration · Life Sciences

From Territory Intuition to a Trusted, Adopted AI System.

A rare disease biologics launch across five EU markets — where a propensity model surfaced a high-value HCP cluster invisible to standard territory planning, and field force adoption was earned through visible, rep-level performance data.

71%of First-Quarter Rx from an AI-Identified Cluster
34%→11%Field Force Override Rate, Weeks 1–12
2.4×Portal Engagement vs. Benchmark

Phase 01 — Objective & Data Readiness

A next-best-action system cannot function without a defined Behavioral Objective — what specific action constitutes success, for which audience, and within what timeframe. Specifying the objective is an input to the model architecture, not an output of it; NBA deployments fail more often at the data layer than at the model layer.

01
Prerequisite 01
HCP Engagement History
Structured, clean records across every touchpoint — minimum 18 months of data with 60%+ of the target population having 3+ engagement records.
02
Prerequisite 02
Prescribing Data
Longitudinal, HCP-linked prescribing data connected to engagement history — the linkage, not the data itself, is the critical dependency.
03
Prerequisite 03
HCP Profile & Archetype
Specialty, setting, and behavioral archetype classification — Independent, Knowledge Seeker, Transactional, Relationship Seeker.
Case Reference · Rare Disease Biologics Launch, 5 EU Markets
Target population: 2,200 specialists across hematology, immunology, and rheumatology. Structural prerequisites in place before NBA deployment: a defined Brand Objective per HCP segment, 44 pre-approved modular components, and a Behavioral Objective specified as first prescription for an eligible patient within 90 days of rep engagement at a defined funnel stage.

Phase 02 — Propensity Model & Signal Architecture

A propensity model answers one question for each HCP: what is the probability that this HCP will achieve the defined Behavioral Objective within the defined timeframe? A true architecture ingests continuous engagement signals and updates recommendations in near-real time — a system that only reads historical data and updates weekly is a scheduling tool, not next-best-action.

◆
Layer 01
Feature Layer
Specialty, volume tier, archetype, engagement history, digital signals, peer network position. Feature engineering typically accounts for 60% of model performance improvement.
◇
Layer 02
Target Layer
Primary target: probability of prescribing initiation within the defined timeframe. Secondary targets: funnel-stage advancement, content engagement probability.
●
Layer 03
Update Cadence
Scores update at least weekly, and within 24 hours of a significant engagement event — signal freshness is a model performance determinant, not a convenience feature.
Featured Result · The Invisible Cluster
The propensity model, trained on 18 months of engagement and prescribing data, identified a 340-HCP cluster with no prior product engagement — invisible to standard territory planning — but with recent congress attendance, an early-adopter peer in their professional network, and a practice profile consistent with the eligible patient population. 71% of first-quarter prescriptions came from this AI-identified cluster.

Phase 03 — Field Force Adoption & Governance

The most technically sophisticated NBA system fails commercially if the field force does not use its recommendations. Adoption is a trust and relevance problem, not primarily a technology problem — reps do not act on recommendations they do not believe are accurate.

I
Integration Element
Explainable Recommendations & Override Mechanism
Every recommendation carries a brief, human-readable rationale. Reps can decline with a structured reason code; override data identifies systematic model failures and is reviewed regularly by model governance.
  • Field force override rate: 34% in weeks 1–4, falling to 11% by week 12
  • Rep-level dashboard: recommendation acceptance rate and conversion rate on NBA-recommended vs. self-selected HCPs
  • Manager-level coaching view: aggregated team acceptance rates correlated with outcomes
II
Governance Requirement
Label Compliance & Consent by Construction
Recommendations are constrained by the approved product label in every market — architecturally explicit, not assumed from training data.
  • Recommending only from a pre-approved modular component library makes label compliance structural, not ad hoc
  • Real-time consent check against opt-out status, channel restrictions, and contact frequency limits
  • Pharmacovigilance-relevant signals routed to reporting without delay from the commercial data pipeline
Why This Result Held
This outcome depended on sequencing, not just modeling: the Behavioral Objective was specified before the propensity model was built, the modular component library existed before recommendations were generated, and field force trust was earned through visible rep-level performance data — not assumed at launch. Rep-level conversion data typically becomes available within 8–12 weeks of launch and is the single most persuasive adoption driver available to commercial leadership.

Ready to Find Your Invisible Cluster?

See the full Personalization & Orchestration capability — the five strategic pillars, next-best-action architecture, and governance model — or discuss a data-readiness assessment directly.

Personalization & Orchestration Capability → Back to Use Cases